Fab’entech, winner in an ambitious European programme, has been awarded 9.2 million euros to develop its treatment against Covid-19 and its variants.

Lyon, 9 December 2021 – The EPIC-CROWN-2 project, initiated by the Lyon-based biotech company, has received funding to the tune of 9.2 million euros from the European Commission. Thanks to this grant, awarded in the context of the first call for HERA projects (HERA is a new European authority dedicated to preparing and responding to …

Fab’entech, winner in an ambitious European programme, has been awarded 9.2 million euros to develop its treatment against Covid-19 and its variants. Read More »